SHULMAN JOHN D — SEC insider filings

SEC reporting owner CIK 1208886. 13 insider filings on record with FilingPulse; latest filed 2026-10-09.

Transaction summary — filings shown

Covers all 13 filings on record, filed 2020-12-03 to 2026-10-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Petros Pharmaceuticals, Inc. (PTPI)Director, 10% owner63 legs · 2,307,580 sh · $4,850,000—6
WRAP TECHNOLOGIES, INC. (WRAP)Director71 leg · 100,000 sh · $110,000—7

Insider filings — SHULMAN JOHN D

FiledFormIssuerReported transactionsSource
2026-10-094WRAP TECHNOLOGIES, INC. (WRAP)Grant/award (A): 21,154 @ $0EDGAR
2026-07-094WRAP TECHNOLOGIES, INC. (WRAP)Purchase (P): 100,000 @ $1.10EDGAR
2026-07-064WRAP TECHNOLOGIES, INC. (WRAP)Grant/award (A): 34,998 (derivative) @ $0EDGAR
2026-05-044WRAP TECHNOLOGIES, INC. (WRAP)Grant/award (A): 19,643 @ $0EDGAR
2026-02-034WRAP TECHNOLOGIES, INC. (WRAP)Grant/award (A): 250,000 @ $2 · Grant/award (A): 250,000 (derivative) @ $0EDGAR
2026-01-054WRAP TECHNOLOGIES, INC. (WRAP)Grant/award (A): 9,394 @ $0EDGAR
2025-12-294WRAP TECHNOLOGIES, INC. (WRAP)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2022-01-034Petros Pharmaceuticals, Inc. (PTPI)
jointly with JCP III SM AIV, L.P., METP Holdings LLC, Juggernaut Partners III GP, L.P., Juggernaut Partners III GP, Ltd.
Purchase (P): 145,773 @ $3.43 · Purchase (P): 109,329 (derivative) @ $0EDGAR
2021-11-304Petros Pharmaceuticals, Inc. (PTPI)
jointly with JCP III SM AIV, L.P., METP Holdings LLC, Juggernaut Partners III GP, L.P., Juggernaut Partners III GP, Ltd.
Purchase (P): 500,000 @ $3 · Purchase (P): 375,000 (derivative) @ $0EDGAR
2021-10-214Petros Pharmaceuticals, Inc. (PTPI)
jointly with JCP III SM AIV, L.P., METP Holdings LLC, Juggernaut Partners III GP, L.P., Juggernaut Partners III GP, Ltd.
Purchase (P): 1,661,807 @ $1.72 · Purchase (P): 1,661,807 (derivative) @ $0EDGAR
2021-04-094Petros Pharmaceuticals, Inc. (PTPI)Grant/award (A): 50,000 (derivative) @ $0EDGAR
2020-12-284/APetros Pharmaceuticals, Inc. (PTPI)
jointly with Juggernaut Partners III GP, L.P., Juggernaut Partners III GP, Ltd., METP Holdings LLC, JCP III SM AIV, L.P., Metuchen Therapeutics, LLC
Grant/award (A): 3,395,964EDGAR
2020-12-034Petros Pharmaceuticals, Inc. (PTPI)Grant/award (A): 3,382,416EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-12-02 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1208886 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs